Epstein-Barr Virus-Associated High-Grade Anaplastic Plasmacytoma in a Renal Transplant Patient

References

• Penn I., Hammond W., Brettschneider L., Starzl T. E. Malignant lymphomas in transplantation patients. Transplantation Proceedings 1969; 1: 106–111
   PubMed Web of Science ®Google Scholar
• Hanto D. W., Frizzera G., Gajl-Peczalska K., Simmons R. L. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferations. Transplantation 1985; 39: 461–467
   PubMed Web of Science ®Google Scholar
• Berg L. C., Copenhaver C. M., Morrison V. A., Gruber S. A., Dunn D. L., Gajl Peczalska K., Strickler J. G. B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization. Human Pathology 1992; 23: 159–163
   PubMed Web of Science ®Google Scholar
• Scheinfeld A. G., Nador R. G., Cesarman E., Chadburn A., Knowles D. M. Epstein-Barr virus latent membrane protein-1 oncogene deletion in posttransplantation lymphoproliferative disorders. American Journal of Pathology 1992; 151: 805–812
   Google Scholar
• Penn J. Immunosuppression: a contributory factor in lymphoma formation. Clinical Transplantation 1992; 6: 214–219
   Web of Science ®Google Scholar
• Joseph G., Barker R., Yan B., Martin A., Medeiros J., Peiper S. Posttransplantation plasma cell dyscrasias. Cancer 1994; 74: 1954–1964
   Google Scholar
• Gordell J. L., Falini B., Erber W., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry 1984; 32: 219–229
   PubMed Web of Science ®Google Scholar
• Stefanaki K., Rontogianni D., Kouvidou C., Bolioti G., Pandelidaki A., Sotsiou F., Kanavaros P. Expression of p53, mdm2, p21/waf1, bcl-2 in thymomas. Histopathology 1997; 30: 549–555
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Kouvidou C., Dai Y., Tzardi M., Datseris G., Darivianaki K. mdm2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression. Journal of Clinical Pathology: Molecular Pathology 1995; 48: M322–325
   Web of Science ®Google Scholar
• Knowles D. M., Cesarman E., Chadburn A., Frizzera G., Chen J., Rose E. A., Michler R. E. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85: 552–565
   PubMed Web of Science ®Google Scholar
• Chadburn A., Cesarman E., Knoeles D. M. Molecular pathology of posttransplantation lymphoproliferative disorders. Seminars in Diagnostic Pathology 1997; 14: 15–26
   PubMed Web of Science ®Google Scholar
• Montagnino G., Lorca E., Tarantini A., Bencini P., Aroldi A., Cesana B., Braga M., Lonati F., Ponticelli C. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clinical Transplantation 1996; 10: 461–469
   PubMed Web of Science ®Google Scholar
• Rojas G., Alberu J., Quintanilla-Martinez L., Lome-Maldonado M. C., Cesarman G., Angeles-Angeles A., Correa-Rotter R. Clinical and pathological charactirization of posttransplantation lymphoproliferative disorders in kidney transplant recipients: single institution experience. Transplantation Proceedings 1996; 28: 3317–3320
   PubMed Web of Science ®Google Scholar
• Wilkinson A. H., Smith J. L., Hunsicker L. G., Tobacman J., Kapelanski D. P., Johnson M., Wright F. H., Behrendt D. M., Corry R. J. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathio-prine, and prednisone. Transplantation 1989; 47: 293–299
   PubMed Web of Science ®Google Scholar
• Harris K. M., Schwartz M. L., Slasky B. S., Nalesnik M., Makowka L. Posttransplantation cyclosporin-induced lymphoproliferative disorders: clinical and radiologic manifestations. Radiology 1987; 162: 697–700
   PubMed Web of Science ®Google Scholar
• Oda D., Persson G. R., Haigh W. G., Sabath D. E., Penn I., Aziz S. Oral presentation of posttransplantation lymphoproliferative disorders. Transplantation 1996; 61: 435–440
   PubMed Web of Science ®Google Scholar
• Delecluse H. J., Anagnostopoulos I., Dallenbach F., Hummel M., Marafioti T., Schneider U., Huhn D., Schmidt-Westhausen A., Reichart P. A., Gross U., Stein H. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 1413–1420
   PubMed Web of Science ®Google Scholar
• Hallek M., Leif Bergsagel P., Anderson K. C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21
   PubMed Web of Science ®Google Scholar